Skip to content

MEDIFAR: what changed

BE 0456.978.480NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€115,474
2024 · €75,116+€40,358
Equity
€869,111
2024 · €899,752-€30,641
Cash
€333,678
2024 · €208,315+€125,363
Balance sheet total
€921,854
2024 · €945,084-€23,230

Largest movements

2024 to 2025
Assets
  • Cash +€125,363

    up €125,363 (+60.2%), from €208,315 to €333,678

    mainly Receivables within one year (+€121,102) and Net result for the year (+€115,474)

  • Receivables within one year -€121,102

    down €121,102 (-49.4%), from €245,297 to €124,195

    of which Other amounts receivable: -€130,985

  • Tangible fixed assets -€39,461

    down €39,461 (-13.6%), from €289,654 to €250,192

Equity and liabilities
  • Reserves -€30,641

    down €30,641 (-3.7%), from €837,752 to €807,111

    of which Distributable reserves: -€30,641

  • Tax, wage and social debts +€16,127

    up €16,127 (+366%), from €4,405 to €20,532

    of which Taxes: +€15,106

  • Trade debts -€16,062

    down €16,062 (-43.5%), from €36,886 to €20,824

  • Other debts +€10,506

    first reported in 2025, at €10,506

Income statement
  • Gross operating margin +€44,197

    up €44,197 (+21.7%), from €203,547 to €247,744

  • Taxes +€14,986

    up €14,986 (+42.2%), from €35,531 to €50,517

  • Staff costs +€4,042

    up €4,042 (+15.8%), from €25,527 to €29,569

  • Depreciation -€3,019

    down €3,019 (-6.8%), from €44,233 to €41,214

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €75,116
Gross operating margin +€44,197
Staff costs -€4,042
Depreciation +€3,019
Other operating charges +€1
Other operating items +€12,901
Financial income -€110
Financial charges -€623
Taxes -€14,986
Result 2025 €115,474
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€278,230
Investment -€6,753
Financing -€146,115
Cash 2024 €208,315
Net result for the year +€115,474
Depreciation +€41,214
Stocks and contracts -€7,794
Receivables within one year +€121,102
Deferred charges and accrued income +€823
Trade debts -€16,062
Tax, wage and social debts +€16,127
Other debts +€10,506
Accrued charges and deferred income -€3,160
Investment in fixed assets (net) -€1,753
Current investments -€5,000
Contributions, distributions and other -€146,115
Cash 2025 €333,678
brings cash intakes cash out
Every line side by side 51 lines
Line Code 2024 2025 Change %
Total assets 20/58 €945,084 €921,854 -€23,230 -2.5%
Fixed assets 21/28 €289,654 €250,192 -€39,461 -13.6%
Tangible fixed assets 22/27 €289,654 €250,192 -€39,461 -13.6%
Land and buildings 22 €125,911 €123,207 -€2,704 -2.1%
Plant, machinery and equipment 23 €101,872 €87,006 -€14,865 -14.6%
Furniture and vehicles 24 €41,375 €25,483 -€15,892 -38.4%
Leasing and similar rights 25 €20,496 €14,496 -€6,000 -29.3%
Current assets 29/58 €655,430 €671,662 +€16,232 +2.5%
Stocks and contracts in progress 3 €192,995 €200,789 +€7,794 +4.0%
Stocks 30/36 €192,995 €200,789 +€7,794 +4.0%
Amounts receivable within one year 40/41 €245,297 €124,195 -€121,102 -49.4%
Trade receivables 40 €114,250 €124,133 +€9,883 +8.7%
Other amounts receivable 41 €131,047 €63 -€130,985 -100.0%
Current investments 50/53 - €5,000 +€5,000
Cash at bank and in hand 54/58 €208,315 €333,678 +€125,363 +60.2%
Deferred charges and accrued income 490/1 €8,823 €8,000 -€823 -9.3%
Total equity and liabilities 10/49 €945,084 €921,854 -€23,230 -2.5%
Equity 10/15 €899,752 €869,111 -€30,641 -3.4%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €837,752 €807,111 -€30,641 -3.7%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Distributable reserves 133 €831,552 €800,911 -€30,641 -3.7%
Profit (loss) carried forward 14 - €0 =
Amounts payable 17/49 €45,333 €52,744 +€7,411 +16.3%
Amounts payable within one year 42/48 €41,292 €51,862 +€10,571 +25.6%
Current portion of amounts payable after more than one year 42 €0 - =
Trade debts 44 €36,886 €20,824 -€16,062 -43.5%
Suppliers 440/4 €36,886 €20,824 -€16,062 -43.5%
Taxes, remuneration and social security 45 €4,405 €20,532 +€16,127 +366%
Taxes 450/3 €1,356 €16,462 +€15,106 +1,114%
Remuneration and social security 454/9 €3,049 €4,070 +€1,021 +33.5%
Other amounts payable 47/48 - €10,506 +€10,506
Accrued charges and deferred income 492/3 €4,041 €881 -€3,160 -78.2%
Non-recurring operating income 76A - €1,104 +€1,104
Remuneration, social security and pensions 62 €25,527 €29,569 +€4,042 +15.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €44,233 €41,214 -€3,019 -6.8%
Other operating charges 640/8 €5,768 €5,768 -€1 0.0%
Non-recurring operating charges 66A €12,901 €0 -€12,901 -100%
Gross operating margin 9900 €203,547 €247,744 +€44,197 +21.7%
Operating profit (loss) 9901 €115,118 €171,194 +€56,076 +48.7%
Financial income 75/76B €177 €67 -€110 -62.0%
Recurring financial income 75 €177 €67 -€110 -62.0%
Financial charges 65/66B €4,648 €5,271 +€623 +13.4%
Recurring financial charges 65 €4,648 €5,271 +€623 +13.4%
Profit (loss) for the period before taxes 9903 €110,647 €165,991 +€55,344 +50.0%
Income taxes 67/77 €35,531 €50,517 +€14,986 +42.2%
Profit (loss) for the period 9904 €75,116 €115,474 +€40,358 +53.7%
Profit (loss) for the period to be appropriated 9905 €75,116 €115,474 +€40,358 +53.7%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€782,341 to €921,455

Midpoint €840,305 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €869,111
Capitalised earnings €695,571 to €973,800
Indication €782,341 to €921,455

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€869,111
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€869,111

Capitalised earnings

net result for the year (9904)
2025
€115,474
excluding non-recurring income and charges
€114,370
2024
€75,116
excluding non-recurring income and charges
€88,016
2023
€89,752
2022
€108,192
2021
€94,796
Average result, excluding non-recurring income and charges
€97,380
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€695,571 / €811,500 / €973,800

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 20 November 2026 via checked.be.